Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Stocks - Dow Ends in Red, but Above Session Lows as Tech, Healthcare Climb

Published 11/05/2020, 20:54
Updated 11/05/2020, 21:08
© Reuters.
US500
-
DJI
-
C
-
BAC
-
JPM
-
SPY
-
GILD
-
NVDA
-
MAR
-
UAA
-
IXIC
-
MRNA
-

By Yasin Ebrahim 

Investing.com – The Dow closed in the red on Monday, but well above session lows, as a rise in healthcare and technology stocks helped offset weakness in financials as fears of second wave of infections reined in recent optimism over a quicker economic recovery as states continue to lift restrictions. 

The Dow Jones Industrial Average fell 0.45%, or 109 points, but had been down about 270 points at the lows of the day. The S&P 500 edged up 0.01%, while the Nasdaq Composite added 0.78%.

Healthcare stocks were among the biggest gainers of the day, led by Gilead Sciences (NASDAQ:GILD), up 4%. Moderna (NASDAQ:MRNA) was up 13%.

Both companies lead the pack of drugmakers in the race to produce potential Covid-19 therapies and vaccines, which would support the long road to global economic recovery at a time when many are concerned that the lifting of restrictions may trigger a second wave of infections.

South Korea and Germany have reported an increase in infections after lifting restrictive measures to contain the virus.

A rise in FAANG stocks, meanwhile, also helped the broader market's comeback from session lows as investors continued to bet that companies sporting solid balance sheets and resilient demand are seemingly better set up for the economic uncertainty ahead.

Chip stocks were also in demand, powered by a jump in shares of Nvidia (NASDAQ:NVDA) following a price target raise on Wall Street.

Nvidia rose more than 3% after Needham boosted its price target on the stock to $360 from $270 on expectations that increased demand for gaming and an uptick in data center spending will boost performance.

The rise in tech helped keep a lid on losses after banking stocks came under pressure as some fear a longer-than-expected economic recovery could increase credit losses for banks. Expectations that the Federal Reserve's benchmark rate could turn negative by April next year also weighed.

JPMorgan (NYSE:JPM) fell 2.8%, Bank of America (NYSE:BAC) slipped 4.2% and Citigroup (NYSE:C) was down 4.9%.

Lower interest rates weigh on a bank's net interest margin, the difference between the interest income generated by banks and the amount of interest paid out to their lenders.

On the earnings front, Under Armour (NYSE:UAA) slumped about 9.4% after reporting that first-quarter sales fell 23% as the Covid-19 pandemic forced the retailer shuttered its stores. 

Marriott International (NASDAQ:MAR) fell 5.5% after missing first-quarter earnings estimates as the pandemic has halted travel and tourism demand.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.